October 4, 2011 — Results of a new study provide no evidence that levodopa accelerates nerve cell death in the substantia nigra in patients with Parkinson's disease (PD). "This means that physicians ...

Whether levodopa is detrimental, beneficial, or without effect on the rate of the progression of Parkinson's disease is unknown and extremely important, both scientifically and clinically. We ...

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the striatum may improve the efficacy of a first-line therapy for Parkinson's ...

Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side-effects with long-term use. A recent human trial found that a new drug ...

Explore Duopa, an advanced Parkinson's disease treatment that uses carbidopa-levodopa gel infusion for steady dopamine levels, reducing motor fluctuations effectively.

University of Arizona researchers have revealed new insights into the neurobiological cause of the involuntary, uncontrollable movement disorders that develop in patients with Parkinson’s disease (PD) ...

Amneal to hold CREXONT launch symposium and scientific presentations at the International Congress of Parkinson’s Disease and Movement Disorders on Sept. 27 – Oct. 1, 2024 “We are pleased to launch ...

Bial has introduced a new sublingual formulation of apomorphine in the UK, offering a fresh treatment option for adults with Parkinson’s disease who experience intermittent OFF episodes that are not ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...